Granahan Investment Management’s Fulgent Genetics FLGT Stock Holding History

Granahan Investment Management’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-227,509	Closed	-$894K	–	197
2018 Q3	$894K	Buy	227,509 +276	+0.1%	+$1.18K	0.05%	181
2018 Q2	$941K	Buy	227,233 +34,229	+18%	+$136K	0.06%	184
2018 Q1	$772K	Sell	193,004 -71,617	-27%	-$315K	0.06%	179
2017 Q4	$1.16M	Buy	264,621 +26,389	+11%	+$101K	0.09%	163
2017 Q3	$1.14M	Buy	238,232 +141,182	+145%	+$812K	0.1%	154
2017 Q2	$620K	Buy	+97,050	New	+$783K	0.06%	163
2017 Q1	–	Sell	-76,800	Closed	-$889K	–	217
2016 Q4	$889K	Buy	+76,800	New	+$725K	0.03%	178

Other funds holding FLGT

OWIM

Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return

Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Granahan Investment Management's FLGT Position: Q4 2018 in Review

Granahan Investment Management sold out of Fulgent Genetics (FLGT) in Q4 2018, closing a stake of 227,509 shares — an estimated $894K sold.

Granahan Investment Management first reported a position in FLGT in Q4 2016 and held it in 7 quarters. The position peaked at $1.16M in Q4 2017. 15 funds tracked by Wall St. Rank hold FLGT as of Q4 2018.

Granahan Investment Management reported no remaining Fulgent Genetics position as of Q4 2018 after selling out during the quarter.
Granahan Investment Management sold 227,509 Fulgent Genetics shares in Q4 2018, an estimated $894K.
Granahan Investment Management first reported a position in Fulgent Genetics in Q4 2016 and held it in 7 quarters.
Granahan Investment Management's Fulgent Genetics position peaked at $1.16M in Q4 2017.
15 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2018.

Based on Granahan Investment Management's 13F filing for Q4 2018, filed 13 Feb 2019.